Only one compound, imetelstat (GRN163L), an oligonucleotide that binds to the RNA subunit of telomerase TERC, has shown efficacy in myeloproliferative disorders, but has displayed limited activity in solid tumors [14, 41, 42]. This evidence concerns the gene TERC and myeloproliferative disorder.